Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Jurcic

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Critical Reviews in Oncology/Hematology|March 20, 2001
Antibody therapy for residual disease in acute myelogenous leukemiaJ G Jurcic
Cytotherapy|October 6, 2007
Ab therapy of AML: native anti-CD33 Ab and drug conjugatesJ G Jurcic
Current Oncology Reports|December 21, 2000
Antibody immunotherapy for leukemiaJ G Jurcic
Cancer Biotherapy & Radiopharmaceuticals|October 21, 2000
Antibody therapy of acute myelogenous leukemiaJ G Jurcic
Current Opinion in Hematology|November 5, 1999
Radionuclides as conditioning before stem cell transplantationJ G Jurcic, D A Scheinberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Radioimmunotherapy of hematological cancer: problems and progressJ G Jurcic, D A Scheinberg
Current Opinion in Immunology|October 1, 1994
Recent developments in the radioimmunotherapy of cancerJ G Jurcic, D A Scheinberg
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Monoclonal antibody therapy of leukemia and lymphomaJ G Jurcic, P C Caron, D A Scheinberg
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Monoclonal antibody therapy of cancerJ G Jurcic, D A Scheinberg, A N Houghton
Current Topics in Microbiology and Immunology|January 16, 2007
Monoclonal antibody therapy of APLP G Maslak, J G Jurcic, D A Scheinberg
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|March 20, 2001
Antibody therapy for residual disease in acute myelogenous leukemiaJ G Jurcic
Cytotherapy|October 6, 2007
Ab therapy of AML: native anti-CD33 Ab and drug conjugatesJ G Jurcic
Current Oncology Reports|December 21, 2000
Antibody immunotherapy for leukemiaJ G Jurcic
Cancer Biotherapy & Radiopharmaceuticals|October 21, 2000
Antibody therapy of acute myelogenous leukemiaJ G Jurcic
Current Opinion in Hematology|November 5, 1999
Radionuclides as conditioning before stem cell transplantationJ G Jurcic, D A Scheinberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Radioimmunotherapy of hematological cancer: problems and progressJ G Jurcic, D A Scheinberg
Current Opinion in Immunology|October 1, 1994
Recent developments in the radioimmunotherapy of cancerJ G Jurcic, D A Scheinberg
Advances in Pharmacology (San Diego, Calif.)|January 1, 1995
Monoclonal antibody therapy of leukemia and lymphomaJ G Jurcic, P C Caron, D A Scheinberg
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Monoclonal antibody therapy of cancerJ G Jurcic, D A Scheinberg, A N Houghton
Current Topics in Microbiology and Immunology|January 16, 2007
Monoclonal antibody therapy of APLP G Maslak, J G Jurcic, D A Scheinberg
Pageof 3